Aureomycin A-377 en es it fr

Aureomycin A-377 Brand names, Aureomycin A-377 Analogs

Aureomycin A-377 Brand Names Mixture

  • No information avaliable

Aureomycin A-377 Chemical_Formula


Aureomycin A-377 RX_link

No information avaliable

Aureomycin A-377 fda sheet

Aureomycin A-377 msds (material safety sheet)

Aureomycin A-377 Synthesis Reference

No information avaliable

Aureomycin A-377 Molecular Weight

478.879 g/mol

Aureomycin A-377 Melting Point

No information avaliable

Aureomycin A-377 H2O Solubility

Soluble (at all physiological pH values)

Aureomycin A-377 State


Aureomycin A-377 LogP


Aureomycin A-377 Dosage Forms


Aureomycin A-377 Indication

For the treatment of infections and to treat acne. It may also be used to treat urinary tract infections, gum disease, and other bacterial infections such as gonorrhea and chlamydia. Lymecycline is also used commonly as a prophylactic treatment for infection by Bacillus anthracis (anthrax). It is also effective against Yersinia pestis and malaria and is also prescribed for the treatment of Lyme disease.

Aureomycin A-377 Pharmacology

Lymecycline is a tetracycline broad-spectrum antibiotic. It is approximately 5000 times more soluble than tetracycline base and is unique amongst tetracyclines in that it is absorbed by the "active transport" process across the intestinal wall, making use of the same fast and efficient mechanism by which carbohydrates are absorbed. It inhibits cell growth by inhibiting translation.

Aureomycin A-377 Absorption

Absorption is fast and efficient. Bioavailability is 100% following oral administration.

Aureomycin A-377 side effects and Toxicity

Adverse effects include nausea, vomiting, diarrhoea, glossitis, enterocolitis, dysphagia, dermatitis, hypersensitivity reactions, proctitis, and vaginitis.

Aureomycin A-377 Patient Information

Aureomycin A-377 Organisms Affected

Enteric bacteria and other eubacteria